UFP Technologies

UFPT

Market cap $1.51B

The S&P 500 continues to advance to new all-time highs, delivering total returns of 15.2% so far in 2025. However, much of this run stems from the "Magnificent Seven" and other massive technology stocks that have an outsize influence on the index.

Investors need to pay close attention to UFPT stock based on the movements in the options market lately.

Explore the exciting world of UFP Industries (UFPT 0.02%) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!

NEWBURYPORT, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (UFPT), today announced Mitch Rock, President, and Ron Lataille, Sr. VP and CFO, will present at the Midwest IDEAS Investor Conference on Tuesday, August 26, 2025, at The InterContinental in Chicago, IL. UFP's presentation is scheduled to begin at 7:55 AM CT. The presentation is webcast and can be accessed through the conference host's main website: https://www.threepartadvisors.com/midwest and in the Investor Relations section of the company's website: http://www.ufpt.com.

UFP Technologies continues to deliver strong organic growth and accretive M&A, creating a defensive, diversified medtech-focused business with robust customer relationships. Recent results show impressive sales and earnings momentum, with adjusted EPS exceeding $10 annualized and leverage remaining very manageable after recent acquisitions. Valuations at 24x earnings are justified by the company's growth trajectory, operational performance, and management's proven M&A execution.

UFP Technologies (UFPT) Q2 EPS Jumps 27%

UFP Technologies, Inc. (NASDAQ:UFPT ) Q2 2025 Earnings Call August 5, 2025 8:30 AM ET Company Participants R. Jeffrey Bailly - CEO & Chairman Ronald J.

UFP Technologies (UFPT) came out with quarterly earnings of $2.5 per share, beating the Zacks Consensus Estimate of $2.29 per share. This compares to earnings of $1.86 per share a year ago.

NEWBURYPORT, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today reported net income of $17.2 million or $2.21 per diluted common share outstanding for its second quarter ended June 30, 2025, compared to net income of $13.6 million or $1.75 per diluted common share outstanding for the same quarter in 2024. Adjusted earnings per diluted common share outstanding grew 27% to $2.50. Sales for the second quarter were $151.2 million compared to sales of $110.2 million in the second quarter of 2024. Net income for the six-month period ended June 30, 2025, was $34.4 million or $4.42 per diluted common share outstanding compared to net income of $26.2 million or $3.38 per diluted common share outstanding for the same period in 2024. Sales for the six-month period ended June 30, 2025, were $299.3 million compared to sales of $215.2 million for the same period in 2024. Throughout this news release, reference is made to non-GAAP measures including organic sales growth, adjusted operating income, adjusted SG&A, adjusted net income and EPS, and EBITDA and adjusted EBITDA. Please see “Non-GAAP Financial Information” at the end of this news release.

NEWBURYPORT, Mass., July 29, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today announced the Company plans to report financial results for the second quarter ended June 30, 2025 on August 4, 2025 after the market close.